About CytoTerra
CytoTerra is a private company based in Seattle, Washington, incorporated in 2025 in Delaware. It has reported $1,315,001 raised in two offerings on Form D since February 2026. Its chief executive is Stephen Eacker.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Oct 7, 2026 | $300,000of $1.0M target | 2 | $150K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 28, 2026 | Feb 10, 2026 | $1,015,001of $2.0M target | 13 | $78,077 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $1,315,001 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CytoTerra's Form D filed Oct 7, 2026.
SE
JS
Jesse Salk
Director
Also a director at Cellens and a chief executive officer and director at TwinStrand Biosciences.
KH
Kenneth Horenstein
Director
SM